Literature DB >> 1997946

Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.

T A Bacon1, E Wickstrom.   

Abstract

Expression of the human protooncogene c-myc is necessary for replication, and may be inhibited in a sequence-specific, dose-dependent manner by an antisense oligodeoxynucleotide specific for the first five codons of c-myc mRNA. Antisense inhibition of c-myc inhibits the proliferation and enhances the differentiation of the HL-60 human promyelocytic leukemia cell line. In order to raise the efficacy of antisense oligomers, HL-60 cells were grown in a serum-free medium so as to minimize nuclease activity in the culture medium. Daily addition of anti-c-myc oligomer was then found to induce terminal granulocytic differentiation of 80% or more of HL-60 cells, and inhibit colony formation by greater than 50%, comparable to 1% Me2SO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997946

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  4 in total

Review 1.  Oligonucleotide treatment of ras-induced tumors in nude mice.

Authors:  E Wickstrom
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

2.  Myc roles in hematopoiesis and leukemia.

Authors:  M Dolores Delgado; Javier León
Journal:  Genes Cancer       Date:  2010-06

3.  Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.

Authors:  Y Huang; R Snyder; M Kligshteyn; E Wickstrom
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

4.  Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion.

Authors:  Huabo Wang; Lokendra Sharma; Jie Lu; Paul Finch; Steven Fletcher; Edward V Prochownik
Journal:  Oncotarget       Date:  2015-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.